ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128,588 | -55.7% | 23,594 | -45.5% | 0.01% | -54.5% |
| Q2 2023 | $290,470 | +35.6% | 43,289 | +78.4% | 0.01% | +22.2% |
| Q1 2023 | $214,269 | -71.6% | 24,266 | -75.4% | 0.01% | -77.5% |
| Q4 2022 | $753,885 | +120.4% | 98,676 | +105.1% | 0.04% | +207.7% |
| Q3 2022 | $342,000 | -62.5% | 48,100 | -57.3% | 0.01% | -66.7% |
| Q2 2022 | $911,000 | -45.9% | 112,589 | -7.2% | 0.04% | -45.8% |
| Q1 2022 | $1,684,000 | +187.4% | 121,320 | +732.8% | 0.07% | +30.9% |
| Q1 2021 | $586,000 | – | 14,567 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |